These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1246 related articles for article (PubMed ID: 18848640)

  • 1. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail.
    Juillerat-Jeanneret L; Schmitt F
    Med Res Rev; 2007 Jul; 27(4):574-90. PubMed ID: 17022028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in strategies to improve drug delivery to brain tumors.
    Newton HB
    Expert Rev Neurother; 2006 Oct; 6(10):1495-509. PubMed ID: 17078789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier.
    Andrieux K; Couvreur P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(5):463-74. PubMed ID: 20049811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active targeting of brain tumors using nanocarriers.
    Béduneau A; Saulnier P; Benoit JP
    Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 3 - Colloidal systems for CNS drug delivery.
    Costantino L; Tosi G; Ruozi B; Bondioli L; Vandelli MA; Forni F
    Prog Brain Res; 2009; 180():35-69. PubMed ID: 20302828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier delivery.
    Pardridge WM
    Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential receptor-mediated drug targeting to the diseased brain.
    Rip J; Schenk GJ; de Boer AG
    Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery to the brain using polymers.
    Domb A; Maniar M; Bogdansky S; Chasin M
    Crit Rev Ther Drug Carrier Syst; 1991; 8(1):1-17. PubMed ID: 1868550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated platform for brain imaging and drug delivery across the blood-brain barrier.
    Iqbal U; Abulrob A; Stanimirovic DB
    Methods Mol Biol; 2011; 686():465-81. PubMed ID: 21082388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery to brain tumours: challenges and progress.
    Ningaraj NS
    Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).
    Ulbrich K; Hekmatara T; Herbert E; Kreuter J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):251-6. PubMed ID: 18805484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound.
    Kinoshita M; McDannold N; Jolesz FA; Hynynen K
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1085-90. PubMed ID: 16403441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
    de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
    Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy delivery issues in central nervous system malignancy: a reality check.
    Muldoon LL; Soussain C; Jahnke K; Johanson C; Siegal T; Smith QR; Hall WA; Hynynen K; Senter PD; Peereboom DM; Neuwelt EA
    J Clin Oncol; 2007 Jun; 25(16):2295-305. PubMed ID: 17538176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.
    Ganta S; Deshpande D; Korde A; Amiji M
    Mol Membr Biol; 2010 Oct; 27(7):260-73. PubMed ID: 20929336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.